AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 2314826 — intervention group
Group type: EXPERIMENTAL
Intervention: Very-high-dose cisplatin (40 mg/m2/day for 5 days)
Number of subjects: 31
Study 2314826 — intervention group
Group type: COMPARATOR
Intervention: Standard-high-dose cisplatin (either a single dose of 100 or 20 mg/m2/day for 5 days)
Number of subjects: 31
Study 303498 — intervention group
Group type: EXPERIMENTAL
Intervention: 100 mg of minocycline twice a day
Number of subjects: 60
Study 303498 — intervention group
Group type: COMPARATOR
Intervention: 75 mg of minocycline twice a day
Number of subjects: 60
Study 30760243 — intervention group
Group type: EXPERIMENTAL
Intervention: Multi-component implementation strategy including obtaining executive support, training in-school champions, provision of tools and resources, implementation prompts, reminders and feedback
Number of subjects: 62
Study 30760243 — intervention group
Group type: COMPARATOR
Intervention: Usual practice
Number of subjects: 62
Study 26718667 — intervention group
Group type: EXPERIMENTAL
Intervention: Enriched formula (ENR)
Number of subjects: 110
Study 26718667 — intervention group
Group type: COMPARATOR
Intervention: Standard formula (ST)
Number of subjects: 110
Study 26718667 — intervention group
Group type: COMPARATOR
Intervention: Both groups (ENR and ST)
Number of subjects: 110
Study 26577642 — intervention group
Group type: EXPERIMENTAL
Intervention: Weiss Functional Impairment Rating Scale-Parent Report Form (WFIRS-P)
Number of subjects: 7
Study 23404824 — intervention group
Group type: COMPARATOR
Intervention: Weight Watchers (WW)
Number of subjects: 141
Study 23404824 — intervention group
Group type: COMPARATOR
Intervention: Combined treatment (CT)
Number of subjects: 141
Study 23404824 — intervention group
Group type: COMPARATOR
Intervention: Behavioral weight loss (BWL)
Number of subjects: 141
Study 22485058 — intervention group
Group type: EXPERIMENTAL
Intervention: Breathing Awareness Meditation (BAM)
Number of subjects: 121
Study 22485058 — intervention group
Group type: EXPERIMENTAL
Intervention: Life Skills (LS) training
Number of subjects: 121
Study 22485058 — intervention group
Group type: COMPARATOR
Intervention: Health Education (HE)
Number of subjects: 121
Study 19761936 — intervention group
Group type: EXPERIMENTAL
Intervention: Atenolol-based therapy
Number of subjects: 12759
Study 19761936 — intervention group
Group type: COMPARATOR
Intervention: Amlodipine-based therapy
Number of subjects: 12759
Study 18093505 — intervention group
Group type: EXPERIMENTAL
Intervention: Calendar reminder of medication taking
Number of subjects: 220
Study 18093505 — intervention group
Group type: COMPARATOR
Intervention: Control group (normal treatment)
Number of subjects: 220
Study 15456436 — intervention group
Group type: EXPERIMENTAL
Intervention: Ropivacaine (active pump)
Number of subjects: 48
Study 15456436 — intervention group
Group type: COMPARATOR
Intervention: Normal saline (placebo pump)
Number of subjects: 48
Study 11448321 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.03% AGN 192024 once daily
Number of subjects: 100
Study 11448321 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.003% AGN 192024 once daily
Number of subjects: 100
Study 11448321 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.01% AGN 192024 once daily
Number of subjects: 100
Study 11448321 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.03% AGN 192024 twice daily
Number of subjects: 100
Study 11448321 — intervention group
Group type: COMPARATOR
Intervention: 0.5% timolol twice daily
Number of subjects: 100
Study 10405567 — intervention group
Group type: EXPERIMENTAL
Intervention: Thrombolytic therapy with alteplase (r-TPA), aspirin, glyceryl trinitrate
Number of subjects: 50
Study 10405567 — intervention group
Group type: EXPERIMENTAL
Intervention: Thrombolytic therapy without reperfusion
Number of subjects: 50
Study 10405567 — intervention group
Group type: COMPARATOR
Intervention: Control group (healthy persons)
Number of subjects: 50
Study 8296887 — intervention group
Group type: EXPERIMENTAL
Intervention: Brief adaptive psychotherapy
Number of subjects: 81
Study 8296887 — intervention group
Group type: EXPERIMENTAL
Intervention: Short-term dynamic psychotherapy
Number of subjects: 81
Study 8296887 — intervention group
Group type: COMPARATOR
Intervention: Waiting list for therapy
Number of subjects: 81
Study 3173455 — intervention group
Group type: EXPERIMENTAL
Intervention: Diet (energy intake reduction)
Number of subjects: 42
Study 3173455 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise (increased energy expenditure)
Number of subjects: 42
Study 3173455 — intervention group
Group type: COMPARATOR
Intervention: Diet and Exercise
Number of subjects: 42
Study 31816875 — intervention group
Group type: EXPERIMENTAL
Intervention: Nordic Diet (ND)
Number of subjects: 88
Study 31816875 — intervention group
Group type: COMPARATOR
Intervention: Control Diet (CD)
Number of subjects: 88
Study 28522220 — intervention group
Group type: EXPERIMENTAL
Intervention: Early ACL reconstruction
Number of subjects: 119
Study 28522220 — intervention group
Group type: COMPARATOR
Intervention: Delayed ACL reconstruction
Number of subjects: 119
Study 28522220 — intervention group
Group type: COMPARATOR
Intervention: Rehabilitation alone
Number of subjects: 119
Study 25869840 — intervention group
Group type: EXPERIMENTAL
Intervention: Microdosing of (14)C-hRESCAP at 53 μg
Number of subjects: 0
Study 25869840 — intervention group
Group type: EXPERIMENTAL
Intervention: Therapeutic doses of hRESCAP (up to 5.3 mg)
Number of subjects: 0
Study 24620701 — intervention group
Group type: EXPERIMENTAL
Intervention: GameCycle
Number of subjects: 19
Study 24620701 — intervention group
Group type: COMPARATOR
Intervention: Saratoga Silver I arm ergometer
Number of subjects: 19
Study 24620701 — intervention group
Group type: EXPERIMENTAL
Intervention: Text message reminders to exercise
Number of subjects: 19
Study 24620701 — intervention group
Group type: COMPARATOR
Intervention: No reminders to exercise
Number of subjects: 19
Study 21880193 — intervention group
Group type: EXPERIMENTAL
Intervention: Salmeterol/Fluticasone Propionate (SAL/FP) 50/250 μg, administered 2 inhalations BID for 2 weeks
Number of subjects: 48
Study 21880193 — intervention group
Group type: COMPARATOR
Intervention: Fluticasone Propionate (FP) 250 μg, administered 2 inhalations BID for 2 weeks
Number of subjects: 48
Study 21880193 — intervention group
Group type: EXPERIMENTAL
Intervention: Salmeterol/Fluticasone Propionate (SAL/FP) 50/250 μg
Number of subjects: 48
Study 21880193 — intervention group
Group type: COMPARATOR
Intervention: Fluticasone Propionate (FP) 250 μg
Number of subjects: 48
Study 19474112 — intervention group
Group type: EXPERIMENTAL
Intervention: Letrozole
Number of subjects: 4895
Study 19474112 — intervention group
Group type: COMPARATOR
Intervention: Tamoxifen
Number of subjects: 4895
Study 17223304 — intervention group
Group type: EXPERIMENTAL
Intervention: Laparoscopic total mesorectal excision (LTME)
Number of subjects: 228
Study 17223304 — intervention group
Group type: COMPARATOR
Intervention: Open total mesorectal excision (OTME)
Number of subjects: 228
Study 15089806 — intervention group
Group type: EXPERIMENTAL
Intervention: Moxonidine 0.4 mg orally
Number of subjects: 12
Study 15089806 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study 11152037 — intervention group
Group type: COMPARATOR
Intervention: Fentanyl-nitrous oxide
Number of subjects: 40
Study 11152037 — intervention group
Group type: EXPERIMENTAL
Intervention: Halothane-nitrous oxide
Number of subjects: 40
Study 11152037 — intervention group
Group type: EXPERIMENTAL
Intervention: Isoflurane-nitrous oxide
Number of subjects: 40
Study 11152037 — intervention group
Group type: EXPERIMENTAL
Intervention: Sevoflurane-nitrous oxide
Number of subjects: 40
Study 9863079 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined acupuncture-drug anesthesia (dolantin 25 mg and droperidol 2.5 mg administered intravenously, with acupuncture stimulation at Neiguan (P6) and Hegu (LI4) for 30 minutes).
Number of subjects: 50
Study 9863079 — intervention group
Group type: COMPARATOR
Intervention: 5% procaine combined with drug anesthesia (control group).
Number of subjects: 50
Study 7868672 — intervention group
Group type: EXPERIMENTAL
Intervention: Reduced glutathione therapy
Number of subjects: 0
Study 3280220 — intervention group
Group type: EXPERIMENTAL
Intervention: Verapamil 80 mg t.i.d. for one week
Number of subjects: 36
Study 3280220 — intervention group
Group type: EXPERIMENTAL
Intervention: Verapamil 120 mg t.i.d. for one week
Number of subjects: 36
Study 3280220 — intervention group
Group type: EXPERIMENTAL
Intervention: Diltiazem 80 mg t.i.d. for one week
Number of subjects: 36
Study 3280220 — intervention group
Group type: EXPERIMENTAL
Intervention: Diltiazem 120 mg t.i.d. for one week
Number of subjects: 36
Study 3280220 — intervention group
Group type: EXPERIMENTAL
Intervention: High dose of both drugs
Number of subjects: 36
Study 3280220 — intervention group
Group type: EXPERIMENTAL
Intervention: Both doses of diltiazem
Number of subjects: 36
Study 3280220 — intervention group
Group type: EXPERIMENTAL
Intervention: Both drugs
Number of subjects: 36
Study 3280220 — intervention group
Group type: EXPERIMENTAL
Intervention: Verapamil
Number of subjects: 36
Study 30649752 — intervention group
Group type: EXPERIMENTAL
Intervention: Tralokinumab every 2 weeks (Q2 W)
Number of subjects: 52
Study 30649752 — intervention group
Group type: EXPERIMENTAL
Intervention: Tralokinumab every 4 weeks (Q4 W)
Number of subjects: 52
Study 30649752 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 52
Study 30649752 — intervention group
Group type: EXPERIMENTAL
Intervention: Tralokinumab
Number of subjects: 52
Study 29354968 — intervention group
Group type: EXPERIMENTAL
Intervention: Electroacupuncture (EA) at specific acupoints (Neixiyan, Dubi, Yanglingquan, Yinlingquan, Xuehai, Liangqiu, Zusanli) with a frequency of 2 Hz for 3 weeks, 11 sessions total.
Number of subjects: 40
Study 29354968 — intervention group
Group type: COMPARATOR
Intervention: Minimal acupuncture at points located 2 cm next to the specified acupoints, no current applied.
Number of subjects: 40
Study 26670300 — intervention group
Group type: EXPERIMENTAL
Intervention: Care Coordination for Health Promotion and Activities in Parkinson's Disease (CHAPS) intervention
Number of subjects: 346
Study 23485520 — intervention group
Group type: EXPERIMENTAL
Intervention: Mediterranean diet (MD)
Number of subjects: 12
Study 23485520 — intervention group
Group type: COMPARATOR
Intervention: Low fat-high carbohydrate diet (LF/HCD)
Number of subjects: 12
Study 21515206 — intervention group
Group type: EXPERIMENTAL
Intervention: Fish-oil-based lipid emulsion (10% Omegaven)
Number of subjects: 28
Study 21515206 — intervention group
Group type: COMPARATOR
Intervention: Control (placebo)
Number of subjects: 28
Study 17393021 — intervention group
Group type: EXPERIMENTAL
Intervention: Enoxaparin 4,000 IU once daily
Number of subjects: 55
Study 17393021 — intervention group
Group type: COMPARATOR
Intervention: Tinzaparin 4,500 IU once daily
Number of subjects: 55
Study 16330294 — intervention group
Group type: COMPARATOR
Intervention: Diflucan (reference; Pfizer Corporation)
Number of subjects: 24
Study 16330294 — intervention group
Group type: COMPARATOR
Intervention: Funzol (test; Bosnalijek d.d.)
Number of subjects: 24
Study 12324912 — intervention group
Group type: EXPERIMENTAL
Intervention: Q(a) (reduction of 1,000 mL/min)
Number of subjects: 105
Study 12324912 — intervention group
Group type: EXPERIMENTAL
Intervention: %UF (increase of 4%)
Number of subjects: 105
Study 12324912 — intervention group
Group type: EXPERIMENTAL
Intervention: MAP (reduction of 30 mm Hg)
Number of subjects: 105
Study 12324912 — intervention group
Group type: EXPERIMENTAL
Intervention: Percentage decrease in Q(a) (> or =20% versus <20%)
Number of subjects: 105
Study 9807203 — intervention group
Group type: EXPERIMENTAL
Intervention: Adjuvant therapy (tamoxifen) in postmenopausal patients
Number of subjects: 360
Study 9807203 — intervention group
Group type: EXPERIMENTAL
Intervention: Polychemotherapy (CMF) in reproductive group
Number of subjects: 360
Study 9807203 — intervention group
Group type: EXPERIMENTAL
Intervention: Hormonal therapy (tamoxifen) in reproductive group
Number of subjects: 360
Study 7657415 — intervention group
Group type: COMPARATOR
Intervention: Caffeine 0 mg.kg body weight-1 (placebo)
Number of subjects: 9
Study 7657415 — intervention group
Group type: EXPERIMENTAL
Intervention: Caffeine 5 mg.kg body weight-1
Number of subjects: 9
Study 7657415 — intervention group
Group type: EXPERIMENTAL
Intervention: Caffeine 9 mg.kg body weight-1
Number of subjects: 9
Study 7657415 — intervention group
Group type: EXPERIMENTAL
Intervention: Caffeine 13 mg.kg body weight-1
Number of subjects: 9
Study 2719903 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral aqueous solution
Number of subjects: 6
Study 2719903 — intervention group
Group type: EXPERIMENTAL
Intervention: Controlled release oral tablet (MST-Continus)
Number of subjects: 6
Study 2719903 — intervention group
Group type: EXPERIMENTAL
Intervention: Controlled release buccal tablet
Number of subjects: 6
Study 2719903 — intervention group
Group type: COMPARATOR
Intervention: Intravenous morphine
Number of subjects: 6
Study 2719903 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral morphine
Number of subjects: 6
Study 2719903 — intervention group
Group type: EXPERIMENTAL
Intervention: Buccal morphine
Number of subjects: 6
Study 1099022 — intervention group
Group type: EXPERIMENTAL
Intervention: Methylphenidate
Number of subjects: 0
Study 1099022 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 29017022 — intervention group
Group type: EXPERIMENTAL
Intervention: Hypertrophic training (HYP I) for 10 weeks
Number of subjects: 0
Study 29017022 — intervention group
Group type: EXPERIMENTAL
Intervention: Maximum strength training (MS) for 10 weeks
Number of subjects: 0
Study 29017022 — intervention group
Group type: EXPERIMENTAL
Intervention: Power training (P) for 10 weeks following MS
Number of subjects: 0
Study 29017022 — intervention group
Group type: EXPERIMENTAL
Intervention: Maximum strength training (MS) followed by power training (P)
Number of subjects: 0
Study 29017022 — intervention group
Group type: EXPERIMENTAL
Intervention: Hypertrophic training (HYP II)
Number of subjects: 0
Study 29017022 — intervention group
Group type: EXPERIMENTAL
Intervention: Maximum strength training (MS) and power training (P)
Number of subjects: 0
Study 29017022 — intervention group
Group type: EXPERIMENTAL
Intervention: RFD parameters
Number of subjects: 0
Study 29017022 — intervention group
Group type: EXPERIMENTAL
Intervention: Monitoring RFD
Number of subjects: 0
Study 27569351 — intervention group
Group type: EXPERIMENTAL
Intervention: Naftopidil 75 mg for 8 weeks
Number of subjects: 31
Study 27569351 — intervention group
Group type: COMPARATOR
Intervention: Tamsulosin 0.2 mg and Solifenacin 5 mg for 8 weeks
Number of subjects: 31
Study 24844611 — intervention group
Group type: EXPERIMENTAL
Intervention: High-Ca group (600 mg of calcium per day)
Number of subjects: 220
Study 24844611 — intervention group
Group type: COMPARATOR
Intervention: Low-Ca group (300 mg of calcium per day)
Number of subjects: 220
Study 24844611 — intervention group
Group type: EXPERIMENTAL
Intervention: Mid-Ca group (300 mg of calcium per day)
Number of subjects: 220
Study 22349456 — intervention group
Group type: EXPERIMENTAL
Intervention: Peer-support intervention designed to improve diabetes self-care behaviors
Number of subjects: 424
Study 22349456 — intervention group
Group type: COMPARATOR
Intervention: Multi-disciplinary diabetes education program
Number of subjects: 424
Study 20185072 — intervention group
Group type: EXPERIMENTAL
Intervention: Pegged glenoid component
Number of subjects: 53
Study 20185072 — intervention group
Group type: COMPARATOR
Intervention: Keeled glenoid component
Number of subjects: 53
Study 19018337 — intervention group
Group type: EXPERIMENTAL
Intervention: Unsedated transnasal gastroscopy
Number of subjects: 20
Study 15961933 — intervention group
Group type: EXPERIMENTAL
Intervention: SEDIsystem (automated analyzer for ESR measurement)
Number of subjects: 150
Study 15961933 — intervention group
Group type: COMPARATOR
Intervention: Westergren method (manual method for ESR measurement)
Number of subjects: 150
Study 14559319 — intervention group
Group type: EXPERIMENTAL
Intervention: 200 microg daily of Se as selenomethionine (SeMet) for 4 weeks
Number of subjects: 22
Study 14559319 — intervention group
Group type: COMPARATOR
Intervention: Placebo for 4 weeks
Number of subjects: 22
Study 10965636 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive-behavioral therapy (CBT)
Number of subjects: 0
Study 10965636 — intervention group
Group type: COMPARATOR
Intervention: Systemic-behavioral family therapy (SBFT)
Number of subjects: 0
Study 10965636 — intervention group
Group type: COMPARATOR
Intervention: Nondirective supportive therapy (NST)
Number of subjects: 0
Study 8783053 — intervention group
Group type: EXPERIMENTAL
Intervention: Experimental mouthrinse containing 0.4% zinc sulphate and 0.15% triclosan
Number of subjects: 0
Study 8783053 — intervention group
Group type: EXPERIMENTAL
Intervention: Experimental mouthrinse group 2
Number of subjects: 0
Study 8783053 — intervention group
Group type: COMPARATOR
Intervention: Control mouthrinse
Number of subjects: 0
Study 8783053 — intervention group
Group type: EXPERIMENTAL
Intervention: Experimental mouthrinse groups
Number of subjects: 0
Study 1479631 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined intervention addressing obsessive-compulsive symptoms and substance abuse
Number of subjects: 60
Study 1479631 — intervention group
Group type: COMPARATOR
Intervention: Substance abuse treatment only
Number of subjects: 60
Study 1479631 — intervention group
Group type: COMPARATOR
Intervention: Attention control group receiving treatment for substance abuse and training in progressive muscle relaxation
Number of subjects: 60
Study 6367665 — intervention group
Group type: EXPERIMENTAL
Intervention: Prazosin hydrochloride (1 mg orally three times a day)
Number of subjects: 19
Study 6367665 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 19
Study 30712461 — intervention group
Group type: EXPERIMENTAL
Intervention: Active rTMS
Number of subjects: 21
Study 30712461 — intervention group
Group type: COMPARATOR
Intervention: Sham stimulation (Control)
Number of subjects: 21
Study 29948524 — intervention group
Group type: EXPERIMENTAL
Intervention: Pit latrine sampling for Giardia lamblia
Number of subjects: 0
Study 29948524 — intervention group
Group type: COMPARATOR
Intervention: Hospital submission samples for Giardia lamblia
Number of subjects: 0
Study 29948524 — intervention group
Group type: EXPERIMENTAL
Intervention: Pit latrine sampling for Cryptosporidium spp.
Number of subjects: 0
Study 27468708 — intervention group
Group type: EXPERIMENTAL
Intervention: L-AGE diet
Number of subjects: 138
Study 27468708 — intervention group
Group type: COMPARATOR
Intervention: Reg-AGE diet
Number of subjects: 138
Study 24456328 — intervention group
Group type: EXPERIMENTAL
Intervention: CERA (continuous erythropoietin receptor activator)
Number of subjects: 94
Study 22581236 — intervention group
Group type: EXPERIMENTAL
Intervention: Active 2-mA tDCS
Number of subjects: 30
Study 22581236 — intervention group
Group type: COMPARATOR
Intervention: Sham stimulation
Number of subjects: 30
Study 19717534 — intervention group
Group type: EXPERIMENTAL
Intervention: Exemestane
Number of subjects: 219
Study 19717534 — intervention group
Group type: COMPARATOR
Intervention: Tamoxifen
Number of subjects: 219
Study 17337164 — intervention group
Group type: EXPERIMENTAL
Intervention: Duloxetine treatment for 7-14 days
Number of subjects: 10
Study 16255011 — intervention group
Group type: EXPERIMENTAL
Intervention: 5 mg/day prednisolone
Number of subjects: 192
Study 16255011 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 192
Study 12000111 — intervention group
Group type: EXPERIMENTAL
Intervention: Internet-based skin cancer triage intervention
Number of subjects: 46
Study 12000111 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 46
Study 10394821 — intervention group
Group type: EXPERIMENTAL
Intervention: Enteral feeding
Number of subjects: 0
Study 10394821 — intervention group
Group type: EXPERIMENTAL
Intervention: Immune‐enhancing diets
Number of subjects: 0
Study 10394821 — intervention group
Group type: EXPERIMENTAL
Intervention: Active components (arginine, glutamine, omega‐3 fats)
Number of subjects: 0
Study 10394821 — intervention group
Group type: COMPARATOR
Intervention: Parenteral feeding
Number of subjects: 0
Study 7493437 — intervention group
Group type: EXPERIMENTAL
Intervention: Cholecystokinin-8 infusion
Number of subjects: 6
Study 7493437 — intervention group
Group type: COMPARATOR
Intervention: Saline infusion
Number of subjects: 6
Study 1801571 — intervention group
Group type: EXPERIMENTAL
Intervention: Red wine flavors with 20 prior exposures
Number of subjects: 34
Study 1801571 — intervention group
Group type: COMPARATOR
Intervention: Red wine flavors with 5 or 0 prior exposures
Number of subjects: 34
Study 1801571 — intervention group
Group type: COMPARATOR
Intervention: Sons of alcoholics
Number of subjects: 34
Study 6638128 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.5% timolol with 0.01% benzalkonium chloride
Number of subjects: 40
Study 6638128 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.5% timolol without benzalkonium chloride
Number of subjects: 40
Study 6638128 — intervention group
Group type: COMPARATOR
Intervention: placebo
Number of subjects: 40
Study 31394914 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral appliance therapy
Number of subjects: 93
Study 29936724 — intervention group
Group type: EXPERIMENTAL
Intervention: Good knowledge of HPV vaccination
Number of subjects: 280
Study 29936724 — intervention group
Group type: EXPERIMENTAL
Intervention: Age of respondents
Number of subjects: 280
Study 29936724 — intervention group
Group type: COMPARATOR
Intervention: Poor knowledge of HPV vaccination
Number of subjects: 280
Study 26791031 — intervention group
Group type: EXPERIMENTAL
Intervention: 3-D planning-assisted implantation
Number of subjects: 56
Study 26791031 — intervention group
Group type: COMPARATOR
Intervention: Freehand insertion of the acetabular cup (Control)
Number of subjects: 56
Study 23836095 — intervention group
Group type: EXPERIMENTAL
Intervention: Psychological help to enhance self-confidence, motivation, and mood management
Number of subjects: 16
Study 23836095 — intervention group
Group type: EXPERIMENTAL
Intervention: Supportive general practice environment
Number of subjects: 16
Study 21517955 — intervention group
Group type: EXPERIMENTAL
Intervention: Prandial + basal insulin
Number of subjects: 46
Study 21517955 — intervention group
Group type: COMPARATOR
Intervention: Basal insulin
Number of subjects: 46
Study 19236501 — intervention group
Group type: EXPERIMENTAL
Intervention: Neuroaid (4 capsules, 3 times daily for 3 months)
Number of subjects: 874
Study 19236501 — intervention group
Group type: COMPARATOR
Intervention: Placebo (4 capsules, 3 times daily for 3 months)
Number of subjects: 874
Study 16810765 — intervention group
Group type: EXPERIMENTAL
Intervention: Electric Knife (EK)
Number of subjects: 220
Study 16810765 — intervention group
Group type: EXPERIMENTAL
Intervention: Electro-Coagulation (EC)
Number of subjects: 220